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Summary
Activation of glycolytic genes by HIF-1 is considered critical for metabolic adaptation to hypoxia through increased conver-
sion of glucose to pyruvate and subsequently to lactate. We found that HIF-1 also actively suppresses metabolism through
the tricarboxylic acid cycle (TCA) by directly trans-activating the gene encoding pyruvate dehydrogenase kinase 1 (PDK1).
PDK1 inactivates the TCA cycle enzyme, pyruvate dehydrogenase (PDH), which converts pyruvate to acetyl-CoA. Forced
PDK1 expression in hypoxic HIF-1a null cells increases ATP levels, attenuates hypoxic ROS generation, and rescues these
cells fromhypoxia-induced apoptosis. These studies reveal a hypoxia-inducedmetabolic switch that shunts glucosemetab-
olites from the mitochondria to glycolysis to maintain ATP production and to prevent toxic ROS production.Introduction
The Pasteur effect, which describes the increased conversion of
glucose to lactate in hypoxic cells, has been considered a critical
cellular metabolic adaptation to hypoxia for over a century. The
molecular basis for the Pasteur effect is thought to result solely
from the activation of glycolysis by hypoxia-inducible transcrip-
tion factors, with mitochondrial respiration passively decreasing
due to the paucity of oxygen. The studies we report here along
with studies by Papandreou et al. (2006), however, indicate that
cellular adaptation to hypoxia also requires an active suppres-
sion of mitochondrial pyruvate catabolism and respiration.
Under normal oxygen tensions, cells catabolize glucose to
pyruvate via glycolytic enzymes. Pyruvate is then taken up by
the mitochondria for further catabolism through the tricarboxylic
acid (TCA) or Krebs cycle, which transfers electrons to the respi-
ratory chain. Electron transport through this chain results in ATP
production and terminates in the donation of electrons to oxy-
gen. In low oxygen tension, in which there is a paucity of oxygen
as an electron acceptor, hypoxic cells are surmised to undergo
anaerobic glycolysis as a default mode. Over the past decade,
however, the adaptation of cells to hypoxia has emerged as
an active process. Increased glycolytic flux requires transcrip-
tional activation of genes encoding glucose transporters and
glycolytic enzymes that is mediated by hypoxia-inducible factor
1 (HIF-1) and/or HIF-2 (Iyer et al., 1998; Seagroves et al., 2001).
HIF-1 is a heterodimeric transcription factor, consisting of HIF-
1a and HIF-1b subunits, which functions as a master regulator
of oxygen homeostasis in all metazoan species (Schofield and
Ratcliffe, 2004; Semenza, 2004). Hypoxic activation of HIF-1
promotes ATP production through increased anaerobic glycoly-
sis, which partially compensates for hypoxic cellular energy
demands. Increased ATP production, however, may not be suf-
ficient for hypoxic adaptation since hypoxia paradoxically
causes oxidative stress from uncontrolled mitochondrial gener-
ation of reactive oxygen species (ROS) that may pose a barrierCELL METABOLISM 3, 177–185, MARCH 2006 ª2006 ELSEVIER INC.for cell survival . ROS, a byproduct of mitochondrial respiration
due to electron transfer to O2, is neutralized by catalase, perox-
iredoxins, and superoxide dismutase. Under hypoxic condi-
tions, however, perturbation in electron transport is associated
with leakage of electrons from the respiratory chain, resulting
in increased ROS that could be toxic to cells if ROS levels are
not attenuated. Here, we report that the hypoxia inducible pyru-
vate dehydrogenase kinase 1 (PDK1) is critical for the attenua-
tion of mitochondrial ROS production, maintenance of ATP
levels, and adaptation to hypoxia.
We initially sought to determine by microarray analysis of
gene expression the overlap of genes responsive to both MYC
and hypoxia using the human B lymphocyte cell line, P493-6,
which contains a tetracycline-repressible MYC allele (Kim
et al., 2004; Schuhmacher et al., 1999). Among the genes highly
induced by hypoxia, PDK1 is also a potential MYC target that
was identified by chromatin immunoprecipitation experiments
(Li et al., 2003). PDK1 was selected for further study because
of its involvement in the regulation of glucose metabolism by
the TCA cycle. We found that the gene encoding pyruvate dehy-
drogenase kinase 1 (PDK1) is a direct target of HIF-1. PDK1
phosphorylates the pyruvate dehydrogenase (PDH) E1a subunit
and inactivates the PDH enzyme complex that converts pyru-
vate to acetyl-coenzyme A, thereby inhibiting pyruvate metabo-
lism via the tricarboxylic acid (TCA) cycle (Holness and Sugden,
2003). Because the TCA cycle is coupled to electron transport,
regulation of the PDH complex by PDK is critical for the attenu-
ation of mitochondrial respiration and ROS production.
We observed that under hypoxic conditions, HIF-1a null
mouse embryo fibroblasts (MEFs) fail to activate PDK1 and
undergo apoptosis that is associated with a dramatic rise in the
level of reactive oxygen species (ROS). Forced expression of
PDK1 increases the levels of ATP and prevents hypoxia-induced
ROS generation and apoptosis. Our studies suggest a failure of
the electron transport chain under hypoxic conditions, which
necessitates the shunting of glucose metabolites away fromDOI 10.1016/j.cmet.2006.02.002 177
A R T I C L Ethe mitochondria by HIF-1-mediated PDK1 expression. This re-
sults in the attenuation of mitochondrial respiration, prevention
of toxic ROS production, and the maintenance of ATP levels.
Results
PDK1 is a direct HIF-1 target gene
Our microarray gene expression analysis of hypoxic P493 cells
revealed the induction of many known hypoxia-responsive
genes including those encoding glucose transporter, glycolytic
enzymes, and VEGF, as well as previously unreported ones
(deposited in Gene Expression Omnibus [GEO] database,
GSE4186). PDK1, which had not been previously reported, is
among 25 genes that were induced at least 4-fold by hypoxia
in P493-6 cells (Table S1 in the Supplemental Data available
with this article online). The hypoxic induction of PDK1 gene ex-
pression was accompanied by a remarkable induction of PDK1
protein as demonstrated by immunoblot assay (Figure 1A).
PDK1 levels were also increased in P493-6 cells exposed to
CoCl2 (Figure 1B), which induces HIF-1 activity by inhibiting O2-
dependent degradation of the HIF-1a subunit (Maxwell et al.,
1999; Wang and Semenza, 1993). To determine whether HIF-1
is necessary for PDK1 induction, we analyzed HIF-1a null
(Hif1a2/2) MEFs (Feldser et al., 1999; Iyer et al., 1998) that also
do not express HIF-2a (data not shown). The dramatic increase
in PDK1 levels in isogenic wild-type MEFs exposed to hypoxia
did not occur in Hif1a2/2MEFs (Figure 1C). Similar results were
obtained by immunoblot assay of hexokinase 2 (HK2), which is
the product of a known HIF-1 target gene (Iyer et al., 1998).
To determine whether PDK1 is a direct target of HIF-1, chro-
matin immunoprecipitation (ChIP) was performed with an anti-
HIF1a antibody, as described for anti-Myc antibody (Kim et al.,
2004), using hypoxic P493-6 cells. For a positive control, we
demonstrated binding of HIF-1 to a known HIF-1 target gene,
VEGF, in chromatin from hypoxic, but not from nonhypoxic, cells
(Figure S1). Since HIF-1 is absent in nonhypoxic cells, it is
expected that HIF-1 bound to target genes would not be
detected. In hypoxic cells, HIF-1a was crosslinked to the PDK1
gene in DNA sequences flanking exon 1 that are enriched with
consensusHIF-1binding sites (Figure 1D). These results indicate
that PDK1 is a direct HIF-1 target gene.
PDK1 rescues hypoxic Hif1a2/2 MEFs
The proliferation of Hif1a2/2 embryonic stem cells may be im-
pairedwhenculturedunder hypoxic conditions for 24–48hr (Car-
meliet et al., 1998; Iyer et al., 1998). The proliferation of Hif1a2/2
MEFswas also impaired after 48 hr of hypoxia (Figure 1E) aswas
previously observed (Seagroves et al., 2001). However, a more
striking defect was observed after 72 hr, with a reduction in cell
number indicating cell death, which was confirmed by demon-
stration of a dramatic increase in annexin V staining, an indicator
of apoptosis (Figure 2C). In contrast, the immortalized wild-type
MEFs are able to proliferate in hypoxia, presumably because
SV40 T-antigen expression in these cells (Feldser et al., 1999)
overcomes the RB-mediated G1 checkpoint that is observed in
moderately hypoxic cells (Gardner et al., 2001).
We hypothesized that active suppression of the TCA cycle
and shunting of pyruvate to lactate via inactivation of PDH by
PDK1 is required for cell survival under prolonged hypoxic con-
ditions. To test this hypothesis, we generatedHif1a2/2 cell pools
with forced overexpression of PDK1 by independent retroviral178infections (Figure 2A). PDK1 overexpression resulted in in-
creased PDH E1a subunit phosphorylation, which was also ob-
served in hypoxic wild-type MEFs (Figure 3). Intriguingly, forced
PDK1 expression was sufficient to permit the proliferation of
hypoxic Hif1a2/2MEFs (Figure 2B) and protect them from hyp-
oxia-induced apoptosis (Figure 2C). By contrast, forced expres-
sion of themurine glycolytic enzyme glucose phosphate isomer-
ase (mGPI) could not rescue hypoxicHif1a2/2MEFs (Figure S2).
Forced expression of PDK1 inhibits hypoxia-induced
apoptosis in the absence of HIF1
Our observation that PDK1 rescued hypoxic HIF-1a null MEFs
suggested that PDK1-mediated inactivation of thePDHcomplex
and shuntingof pyruvate away from theTCAcycle towardglycol-
ysis was sufficient for the survival of hypoxic cells. We hypothe-
sized that limited O2 availability may lead to increased ROS
production due to ineffective electron transfer in the mitochon-
dria if flux through the TCA cycle is not attenuated (Balaban
et al., 2005; Yankovskaya et al., 2003). Increased ROS levels
could, in turn, trigger apoptosis (Balaban et al., 2005). As shown
in Figure 4A, hypoxia caused an increase in intracellular H2O2 in
Hif1a2/2MEFs in sharp contrast to the reduction in H2O2 levels
that was observed when wild-type MEFs were exposed to hyp-
oxia. These data taken together with the demonstration that
forced PDK1 expression prevented hypoxia-induced apoptosis
of Hif1a2/2 MEFs raised the possibility that HIF-1-induced
PDK1 activity may reduce ROS production. As shown in
Figure 4B, production of H2O2 in hypoxic Hif1a
2/2 MEFs was
significantly decreased by forced PDK1 expression. To further
confirm that PDK1 reduces ROS production, we examined intra-
cellular oxidants by staining cells with H2DCFDA, which is
oxidized by ROS to the highly fluorescent DCF. DCF fluores-
cence was markedly diminished by forced PDK1 expression in
Hif1a2/2 MEFs (Figure 4C). Furthermore, we hypothesized that
inhibition of mitochondrial electron transport would also rescue
the Hif1a2/2 MEFs. While complex 3 inhibitors, myxothiazol
and antimycin A, were toxic to both normoxic and hypoxic
Hif1a2/2 MEFs, the mitochondrial complex 1 inhibitor rotenone
was able to rescue hypoxic Hif1a2/2MEFs, whereas it inhibited
proliferation of normoxic Hif1a2/2 MEFs (Figure 4D). These re-
sults support a novel regulatory mechanism for hypoxic adapta-
tion in which PDK1 inactivates the PDH complex and inhibits the
TCA cycle, thereby attenuating ROS production.
We hypothesized that PDK1-mediated inhibition of the TCA
cycle would result in increased glycolysis and ATP levels by
shunting pyruvate toward lactate production. ATP content in
Hif1a2/2 MEFs was reduced in hypoxia as compared with
wild-type MEFs (Figure 4E). The decrease in ATP level could
result from decreased ATP production as well as increased
mitochondrial ATP consumption to maintain mitochondrial
membrane potential. In contrast, hypoxic Hif1a2/2 MEFs with
forced PDK1 expression had elevated ATP levels as compared
with hypoxic wild-type MEFs (Figure 4E). The increased ATP
levels, hence, could result from increase ATP production by gly-
colysis and/or fromdecreased ATP consumption tomaintainmi-
tochondrial membrane potential in hypoxia.
Reduced PDK1 levels impair the growth
of hypoxic P493-6 cells
To determine whether PDK1 is necessary for hypoxic adapta-
tion of P493-6 cells, which express predominantly PDK1 (asCELL METABOLISM : MARCH 2006
PDK1 mediates hypoxic metabolic adaptationFigure 1. HIF-1-dependent induction of PDK1 expression in hypoxic cells
A) Immunoblot assay of PDK1 protein levels in hypoxic or normoxic P493-6 cells that were exposed to 0.1% or 20%O2, respectively. b-actin is shown as a loading control.
B) PDK1 induction in P493-6 cells exposed to 100 mM CoCl2 under normoxic (20% O2) conditions. Total protein staining is shown as a loading control.
C) Immunoblot assay of PDK1 and hexokinase 2 expression in wild-type andHif1a2/2MEFs under hypoxic (0.5%O2) or normoxic (20%O2) conditions. b-actin is shown as
a loading control.
D)Chromatin immunoprecipitation assay of the humanPDK1 gene. Real-time PCRquantification of HIF1a binding to regions 1–4 (amplicons) is indicated as the percentage
of total input chromatin DNA. Arrows indicate consensus HIF-1 binding site.
E) Growth curves of the wild-type and Hif1a2/2 MEFs in hypoxic conditions (0.5% O2). Cell numbers (mean 6 SD) from three independent experiments are shown.compared to the three other PDK isoforms), we reduced the ex-
pression of PDK1 by RNA interference (Figure 5A). The growth of
P493-6 cells in hypoxia was impaired by small interfering RNA
(siRNA) directed against PDK1 as compared to cells treatedCELL METABOLISM : MARCH 2006with a scrambled control siRNA that did not reduce PDK1 ex-
pression (Figure 5B). These results are consistent with the hy-
pothesis that PDK1 is necessary for the proliferation of P493-6
cells under hypoxic conditions.179
A R T I C L EFigure 2. Effect of forced PDK1 expression on the survival of hypoxic Hif1a2/2 MEFs
A) Immunoblot assays of PDK1 and HK2 expression in Hif1a2/2MEFs ectopically expressing PDK1 by pMSCVpuro-PDK1 retroviral transduction after 24–72 hr of hypoxia
(0.5% O2). Two independently transduced cell pools with pMSCVpuro-PDK1 retrovirus (#1 and #2) were used. Hif1a
2/2 MEFs and those transduced with empty
pMSCVpuro vector were used as controls. b-actin is shown as a loading control.
B) Growth curves of retrovirally transduced Hif1a2/2 MEFs under hypoxia (0.5% O2). Cell numbers (mean 6 SD) from four independent experiments are shown.
C)Measurement of apoptosis by Annexin V staining after 72 hr of hypoxia (0.5% O2). Percentage of apoptotic cells (Annexin V positive, 7-AAD negative, right lower quad-
rant; mean 6 S.D.) from three independent experiments are shown.Discussion
Pasteur described over a century ago that hypoxic cells increase
the conversion of glucose to lactate, an effect that to date had
been primarily attributed to the activation of glycolysis by hyp-
oxia-inducible transcription factors HIF1a and/or HIF2a. The ac-180companying decrease in cellular respiration in hypoxia was
thought to result passively from the paucity of oxygen, which is
required for accepting electrons from the mitochondrial respira-
tory chain. Our observations along with Papandreou et al. (2006)
reveal that adaptation to hypoxia critically depends on the active
inhibition of mitochondrial pyruvate metabolism and respiration.CELL METABOLISM : MARCH 2006
PDK1 mediates hypoxic metabolic adaptationFigure 3. Phosphorylation of PDH E1a subunit by
PDK1 expression
A) Immunoblot (IB) analysis of PDH E1a subunit
(41 kDa) after two dimensional gel electrophoresis
of lysates from the Hif1a2/2 MEFs expressing
PDK1 or those transduced with empty vector. Filters
were stripped and re-probed for b-actin, which is
shown as an intergel reference point for the immuno-
blot alignment. The very far left lane of each panel
represents one-dimensional electrophoresis of the
lysates.
B) Phosphorylation of PDHE1a in hypoxic (0.5% O2)
wild-type MEFs compared to normoxic (20% O2)
cells. Arrows indicate a phosphorylated form of
PDH E1a subunit. pI = isoelectric points.In addition to our finding that PDK1 is hypoxia inducible from
microarray gene expression analysis, we found that PDK1 is
a direct target of HIF-1 by chromatin immunoprecipitation, which
demonstrates binding of HIF-1 to the promoter region of PDK1.
The accompanying paper by Papandreou et al. (2006) further
confirms that PDK1 is a direct HIF-1 target through PDK1
promoter-reporter assays using a constitutively active HIF-1
expression vector.
Having established thatPDK1 is a direct HIF-1 target, wewere
intrigued and surprised by our finding that PDK1 is sufficient to
rescue hypoxic cells that lack the expression of HIF-1a or HIF-
2a. Our further studies support a novel regulatory mechanism
for hypoxic adaptation whereby hypoxia-induced PDK activity
inhibits PDH, causing the shunting of pyruvate from the mito-
chondria and subsequently attenuating mitochondrial respira-
tion and ROS production. Although we cannot rule out the pos-
sibility that PDK1 may have phosphorylation targets other than
PDH that may promote survival in hypoxia, our study along with
the study by Papandreou et al. (2006) strongly suggests that
PDK1 suppression of the TCA cycle, mitochondrial respiration
and ROS production, and augmentation of ATP levels are crucial
for the survival of hypoxic cells. Thus, HIF-1 plays three critical
roles in the hypoxia-induced metabolic switch from oxidative to
glycolytic metabolism. HIF-1 induces expression of: (1) upstream
glucose transporters and glycolytic enzymes to increase flux fromCELL METABOLISM : MARCH 2006glucose to pyruvate; (2) PDK1 to block the conversion of pyruvate
to acetyl CoA; and (3) lactate dehydrogenase A to convert pyru-
vate to lactate (Figure 6). In this context, we propose that the in-
duction of PDK1 is necessary to prevent excessive mitochondrial
ROS production and to shunt pyruvate toward lactate and regen-
erate NAD+, which permits continued glycolysis and ATP produc-
tion under hypoxia (Figure 6). This model is compatible with find-
ings that hypoxia-induced mitochondrial ROS is necessary and
sufficient for the stabilization of HIF-1 (Brunelle et al., 2005; Guzy
et al., 2005; Kaelin, 2005), which would in turn activate PDK1
and thereby attenuate the persistence of potentially lethal ROS.
It is notable that enforced PDK1 expression increased lactate
production by Hif1a2/2MEFs under nonhypoxic conditions, but
this increase was not readily apparent in hypoxia (data not
shown), suggesting that increased ATP levels with enforced
PDK1 expression in hypoxia may not be due only to glycolysis.
Along with the findings by Papandreou et al. (2006) that PDK1
decreases mitochondrial oxygen consumption and function,
our observations suggest that enforced PDK1 expression res-
cuedHif1a2/2MEFs by inactivating PDH, decreasingmitochon-
drial oxygen consumption and function, thereby reducing
hypoxic mitochondrial ATP consumption for maintenance of
mitochondrial membrane potential.
Further investigation of this fundamental mechanism for regu-
lating cellular metabolism will allow us to better understand the181
A R T I C L EFigure 4. Effect of PDK1 on hypoxia-induced ROS production
A) Intracellular hydrogen peroxide levels in wild-type and Hif1a2/2MEFs after 72 hr at 0.5% or 20% O2. The data are expressed as the mean fluorescence levels from two
independent experiments normalized by protein concentration and shown as normalized (to Hif1a2/2 MEF) values. Error bars represents SEM.
B) Intracellular hydrogen peroxide level inHif1a2/2MEFs ectopically expressing PDK1 or transduced with empty vector after 72 hr of hypoxia (0.5%O2). Four independent
experiments were performed and error bars represent SEM.
C)DCF fluorescence staining of hypoxic (0.5%O2)Hif1a
2/2MEFs transducedwith relevant retroviruses. Imageswere captured with identical photographic exposure times
from two randomly selected fields. As a positive control, Hif1a2/2MEFs ectopically expressing PDK1 were incubated with 200 mM hydrogen peroxide for 4 hr in hypoxia
before staining (right panels).
D) Growth curves of hypoxic (0.5% O2, left panel) or normoxic (20% O2, right panel) Hif1a
2/2MEFs incubated with 0.1 mM rotenone. Cell numbers (mean6 S.D) from two
independent experiments, each measured in duplicate are shown.
E) Intracellular ATP levels of wild-type MEFs, Hif1a2/2MEFs ectopically expressing PDK1 or transduced with empty vector after 72 hr of hypoxia (0.5% O2) or normoxia
(20% O2). Values are normalized to those of normoxic Hif1a
2/2 MEFs.182 CELL METABOLISM : MARCH 2006
PDK1 mediates hypoxic metabolic adaptationFigure 5. Effect of decreased PDK1 expression on
P493-6 cells exposed to hypoxia
A) Immunoblot assays of PDK1 expression in cells
following electroporation with PDK1 siRNA or control
scrambled siRNA in hypoxic (0.1% O2) or normoxic
(20% O2) conditions. b-actin is shown as a loading
control.
B–C) Growth curves of cells electroporated with
PDK1 siRNA or control scrambled siRNA in hypoxia
(B) and normoxia (C). Cell numbers (mean 6 SD)
from two independent experiments, each measured
in duplicate, are shown.physiologic adaptation of normal cells to hypoxia and may also
provide new insights into the Warburg effect or the reliance of
cancer cells on glycolyticmetabolism even under aerobic condi-
tions (Dang and Semenza, 1999; Elstrom et al., 2004). In partic-
ular, the activation of PDK under nonhypoxic conditions would
favor the conversion of glucose to lactate, which is a key feature
of the Warburg effect. Both Myc and HIF-1 activate overlapping
sets of glycolytic genes including lactate dehydrogenase (Kim
et al., 2004), and hence Myc is hypothesized to play a role inCELL METABOLISM : MARCH 2006the Warburg effect. While nonhypoxic activation of HIF-1
through specific signal transduction pathways or loss of VHL
could increase PDK1 and trigger the Warburg effect, the role of
Myc in activating PDK1 is currently unclear. Although Myc was
observed to bind the promoters of PDK1, PDK2, and PDK3 in
the Burkitt’s lymphoma cell line, Daudi (Li et al., 2003), PDK1 ex-
pression was not further increased by enforced Myc expression
in the P493-6 cells. Notwithstanding the as yet unclear role of
Myc in regulating PDK1, which requires further study, our novelFigure 6. Coordinate regulation of hypoxia-induced
metabolic switches by HIF-1
In hypoxic cells, HIF-1 stimulates increased glyco-
lytic flux to pyruvate (1) and its reduction to lactate (2).
In addition, HIF-1-induced PDK1 activity inhibits
PDH (3), resulting in decreased flux through the
TCA cycle. The resulting attenuation of oxidative
phosphorylation is essential to prevent the genera-
tion of reactive oxygen species (ROS) resulting
from ineffective electron transport under hypoxic
conditions. HIF-1 mediates these effects through
transcriptional activation of genes encoding glucose
transporters and glycolytic enzymes (1), lactate de-
hydrogenase A (2), and PDK1 (3).183
A R T I C L Efinding that HIF-1 dependent activation of PDK1 is essential for
cellular adaptation to hypoxia suggests a possible target for can-
cer therapeutic intervention. In particular, the decreased viability
of P493-6 cells with reduced PDK1 level in hypoxia suggests the
possibility of novel approaches that induce apoptosis in hypoxic
cancer cells by PDK inhibition.
Experimental Procedures
Cell culture and hypoxic exposures
Wild-type and Hif1a2/2 MEFs were immortalized by SV-40 large T antigen
and maintained in high glucose (4.5 mg/ml) DMEM (GIBCO/BRL) with 15%
fetal bovine serum (FBS) (GIBCO/BRL), 2 mM sodium pyruvate (Sigma), non-
essential amino acids (Sigma), and 1% penicillin-streptomycin (GIBCO/
BRL)(Feldser et al., 1999). The human Burkitt’s lymphoma cell line P493-6
was generated and maintained as described (Kim et al., 2004; Schuhmacher
et al., 1999). Normoxic cells (20% O2) were maintained at 37ºC in a 5% CO2/
95% air incubator. Hypoxic cells (0.1%–0.5% O2) were maintained in a con-
trol atmosphere chamber (Plas-Labs) at 37ºC. Oxygen tension was moni-
tored by a calibrated Series 200 Percent oxygen analyzer (Alpha Omega
Instruments).
Vectors and retrovirus infection
Verified full-length cDNA clones for human PDK1 were purchased fromOpen
biosystems. Full-length human PDK1 cDNAwas ligated into the pMSCVpuro
(Clontech) retroviral vector (pMSCVpuro-PDK1). Retroviruses were pro-
duced by transfecting the pMSCVpuro-PDK1 or empty pMSCVpuro vector
into the ecotropic Phoenix packaging cell line. Hif1a2/2MEFs were infected
with retroviruses in the presence of 8 mg/ml polybrene (Sigma). Infected cells
were selected with 2 mg/ml puromycin (Sigma).
ChIP assay
Chromatin immunoprecipitation and real-time PCR quantification were per-
formed as described (Kim et al., 2004). The rabbit polyclonal HIF1a antibody
(Novus Biologicals) and rabbit IgG1 antibody (Zymed) were used for immuno-
precipitation (see Table S2 for the primer sequences for the ChIP assay).
Western blot analysis
Proteins extracted from MEFs or P493-6 cells were fractionated by 10%
SDS-PAGE. Polyclonal anti-PDK1 antibody (Stressgen Bioreagents), poly-
clonal anti-HK2 antibody (Santa Cruz) and monoclonal anti-b actin antibody
(Sigma) were used for immunoblot assays.
Cell proliferation and apoptosis
For the cell proliferation assay, 2 3 105 MEFs were plated in a 10 cm dish 1
day before hypoxic exposure (0.5% O2). At indicated times, cells were tryp-
sinized and viable cells were counted. Apoptotic rate was measured by
Annexin V-PE Apoptosis Detection kit (BD Biosciences) according to the
manufacturer’s instructions.
ROS measurements
Intracellular hydrogen peroxide levels were measured using an Amplex Red
Hydrogen Peroxide Assay kit (Molecular Probes) according to the manufac-
turer’s instructions. In brief, total cell lysates were harvested at 72 hr of hyp-
oxic incubation (0.5%O2) inside the hypoxic chamber and the reactions were
initiated immediately by adding Amplex Red reaction mixture. Fluorescence
was measured on a Cytofluor 2300 (Millipore). Fluorescence levels were nor-
malized to the protein concentration. Intracellular ROS production was also
measured by staining with dichlorodihydrofluorescein diacetate (H2DCFDA,
Molecular Probes). After 72 hr of hypoxic incubation (0.5% O2), cells were
loadedwith 5 mMH2DCFDA for 1 hr, washed in PBS, and incubatedwith fresh
media without H2DCFDA for 30 min. DCF fluorescence was visualized using
an Axiovert 200 inverted fluorescence microscope (Zeiss).
Intracellular ATP level measurements
Intracellular ATP levels were measured using an ATPLite assay kit (Perkin El-
mer) according to the manufacturer’s instructions. In brief, cell lysates were
collected from hypoxic (0.5% O2) or normoxic (20% O2) MEFs. Lumines-184cence was measured using an LMax microplate luminescence reader (Mo-
lecular Device), and normalized to the protein concentration.
siRNA experiments
siRNA targeting human PDK1was designed and purchased fromDharmacon
Research Inc. 3 3 106 P493-6 cells were electroporated (1500 mF and 240
volts) with 100 nM PDK1 siRNA (50-CUACAUGAGUCGCAUUUCAdTdT-30)
or scrambled control siRNA (50-CACGCUCGGUCAAAAGGUUdTdT-30) in
a 4 mm cuvette (BTX) using a Gene Pulser Xcell (Bio-Rad). On the following
day, 5 3 105 viable cells subjected to the hypoxic exposure (0.1% O2). At
the indicated times, viable cells were counted and protein lysates were
prepared for immunoblot assays.
2-D electrophoresis
After washes with low-salt wash buffer, cells were extracted in lysis buffer
(8 M urea, 4% CHAPS, 1.5% 3-10 IPG buffer, protease and phosphatase in-
hibitor cocktail). The crude cell homogenate was sonicated on ice, and the
first-dimension isoelectric focusing and second-dimension electrophoresis
were performed as describedwithmodifications(Gorg et al., 1988). After sec-
ond-dimension electrophoresis, proteins were transferred to nitrocellulose
membrane and immunoblotted with monoclonal anti-PDH E1a antibody
(Molecular Probes) or monoclonal anti-b-actin antibody (Sigma).
Microarray analysis
P493-6 cellswere incubated in normoxic (20%O2) or hypoxic condition (0.1%
O2) for 29 hr. Duplicate mRNA samples were prepared from cells from biolog-
ically independent experiments and subjected to Affymetrix oligonucleotide
microarray analysis by using an HG_U133A chip as described (Chou et al.,
2004). To estimate the gene expression signals, data analysis was conducted
on the microarrays’ CEL file probe signal values at the Affymetrix probe pair
(perfect match [PM] probe and mismatch [MM] probe) level, using the statis-
tical algorithm Robust Multiarray Analysis (RMA) (Irizarry et al., 2003) with the
bioconductor package Affy. This probe level data processing includes a nor-
malization procedure utilizing quantile normalization (Bolstad et al., 2003) to
reduce the obscuring variation between microarrays, which might be intro-
duced during the processes of sample preparation, manufacture, fluores-
cence labeling, hybridization and/or scanning. Fold changes were computed
based on the signal intensities estimated above. All computation was done in
R environment.
Supplemental data
Supplemental data include two figures and three tables and can be found
with this article online at http://www.cellmetabolism.org/cgi/content/full/3/
3/177/DC1/.
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